Invitrogen to Acquire Dynal Biotech
Invitrogen is acquiring Dynal Biotech from majority owner Nordic Capital and a co-investor for approximately NOK 2.5 billion.
network
Invitrogen is acquiring Dynal Biotech from majority owner Nordic Capital and a co-investor for approximately NOK 2.5 billion.
The owner/founder of Bloglines [Mark Fletcher] confirms the acquisition rumors on his blog this morning. Here's the post from Mark's…
Fiat and GM have yet to come to an agreement on whether or not GM will buy Fiat's car division.
Eastman Kodak is acquiring Creo, a supplier of prepress systems used by commercial printers worldwide.
Procter & Gamble has signed a deal to acquire 100% of The Gillette Company in a $57 billion transaction.
Monsanto has signed an agreement to acquire Seminis for $1.4 billion in cash and assumed debt.
Mylan Laboratories will most likely not close on a merger with King Pharmaceuticals under the current terms.
Six Apart, the parent company behind hosted blogging service TypePad and publishing platform Movable Type, is about to acquire Live…
Oracle announced that PeopleSoft stockholders have tendered approximately 75 percent of PeopleSoft outstanding stock, giving Oracle control of the company.
Sterling Commerce, has agreed to purchase Yantra Corporation for approximately $170 million in cash.